- Home
- EBON vs KALA Comparison
EBON vs KALA Comparison
Compare EBON & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- KALA
- Stock Information
- Founded
- EBON 2010
- KALA 2009
- Country
- EBON China
- KALA United States
- Employees
- EBON N/A
- KALA N/A
- Industry
- EBON Semiconductors
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- EBON Technology
- KALA Health Care
- Exchange
- EBON Nasdaq
- KALA Nasdaq
- Market Cap
- EBON 25.3M
- KALA 26.2M
- IPO Year
- EBON 2020
- KALA 2017
- Fundamental
- Price
- EBON $4.25
- KALA $7.86
- Analyst Decision
- EBON
- KALA Strong Buy
- Analyst Count
- EBON 0
- KALA 3
- Target Price
- EBON N/A
- KALA $14.00
- AVG Volume (30 Days)
- EBON 36.7K
- KALA 204.0K
- Earning Date
- EBON 08-22-2025
- KALA 08-05-2025
- Dividend Yield
- EBON N/A
- KALA N/A
- EPS Growth
- EBON N/A
- KALA N/A
- EPS
- EBON N/A
- KALA N/A
- Revenue
- EBON $5,868,771.00
- KALA N/A
- Revenue This Year
- EBON N/A
- KALA N/A
- Revenue Next Year
- EBON N/A
- KALA N/A
- P/E Ratio
- EBON N/A
- KALA N/A
- Revenue Growth
- EBON 20.88
- KALA N/A
- 52 Week Low
- EBON $3.00
- KALA $2.92
- 52 Week High
- EBON $10.94
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- EBON 51.94
- KALA 74.24
- Support Level
- EBON $4.25
- KALA $5.35
- Resistance Level
- EBON $5.10
- KALA $8.49
- Average True Range (ATR)
- EBON 0.39
- KALA 0.79
- MACD
- EBON -0.04
- KALA 0.24
- Stochastic Oscillator
- EBON 49.36
- KALA 97.13
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.